Evidence map›Paper›PMID 21966447›Full record

ArticlePloS one2011

Temporal regulation of rapamycin on memory CTL programming by IL-12.

Xiangdong Li, Karla Garcia, Zhifeng Sun, Zhengguo Xiao

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Rapamycin Improves the Response of Effector and Memory CD8Frontiers in cellular and infection microbiology · 2021
    Article
  4. Article
  5. Article
  6. Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  7. Facile assembly and loading of theranostic polymersomes via multi-impingement flash nanoprecipitation.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Repetitive peptide boosting progressively enhances functional memory CTLs.Biochemical and biophysical research communications · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiangdong LiDepartment of Animal and Avian Sciences, University of Maryland, College Park, Maryland, United States of America.
Karla Garcia
Zhifeng Sun
Zhengguo Xiao

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian target of rapamycin (mTOR) is a master regulator of cell growth. Recent reports have defined its important role in memory cytotoxic T lymphocyte (CTL) differentiation in infections and memory programming. We report that rapamycin regulated memory CTL programming by IL-12 to a similar level in a wide range of concentrations, and the enhanced memory CTLs by rapamycin were functional and provided similar protection against Listeria Monocytogenes challenge compared to the control. In addition, rapamycin-experienced CTLs went through substantially enhanced proliferation after transfer into recipients. Furthermore, the regulatory function of rapamycin on CD62L expression in memory CTLs was mainly contributed by the presence of rapamycin in the first 24-hr of stimulation in vitro, whereas the effective window of rapamycin on the size of memory CTLs was determined between 24 to 72 hrs. In conclusion, rapamycin regulates IL-12-driven programming of CTLs to a similar level in a wide range of concentrations, and regulates the phenotype and the size of memory CTLs in different temporal windows.

Indexed as

AnimalsCells, CulturedFlow CytometryImmunologic MemoryInterleukin-12L-SelectinMiceReverse Transcriptase Polymerase Chain ReactionSirolimusT-Lymphocytes, CytotoxicInterleukin-12L-SelectinSirolimus

Identifiers

PMID21966447
PMCPMC3179471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.